KRAS and lung carcinoma: AZD1775, an inhibitor of the G2-M cell cycle checkpoint protein WEE1, in combination with cisplatin or radiation enhanced DNA damages through bypass of the G2-M checkpoint and improved survival of mice with Kras and Lkb1 co-mutant lung cancer (Richer et al., 2017).